EMR Investors - Our Quick Report For You.

Large-cap Technology company Emerson Electric Company has moved -0.0% so far today on a volume of 252,859, compared to its average of 2,739,475. In contrast, the S&P 500 index moved 1.0%.

Emerson Electric Company trades -10.53% away from its average analyst target price of $107.38 per share. The 21 analysts following the stock have set target prices ranging from $90.0 to $120.0, and on average have given Emerson Electric Company a rating of buy.

If you are considering an investment in EMR, you'll want to know the following:

  • Emerson Electric Company's current price is 66.3% above its Graham number of $57.77, which implies that at its current valuation it does not offer a margin of safety

  • Emerson Electric Company has moved 12.0% over the last year, and the S&P 500 logged a change of 8.0%

  • Based on its trailing earnings per share of 5.58, Emerson Electric Company has a trailing 12 month Price to Earnings (P/E) ratio of 17.2 while the S&P 500 average is 15.97

  • EMR has a forward P/E ratio of 19.5 based on its forward 12 month price to earnings (EPS) of $4.92 per share

  • The company has a price to earnings growth (PEG) ratio of 2.16 — a number near or below 1 signifying that Emerson Electric Company is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 2.78 compared to its sector average of 6.23

  • Emerson Electric Co., a technology and engineering company, provides various solutions for customers in industrial, commercial, and consumer markets in the Americas, Asia, the Middle East, Africa, and Europe.

  • Based in Saint Louis, the company has 85,500 full time employees and a market cap of $54.91 Billion. Emerson Electric Company currently returns an annual dividend yield of 2.2%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.